Leap Therapeutics Funding: $99M Raised, Series B

Leap Therapeutics funding overview

Leap Therapeutics is based in Cambridge, MA. Leap Therapeutics has raised $99M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include Winklevoss Capital.

Leap Therapeutics at a glance

Total raised

$99M

Latest round

Series B

Headquarters

Cambridge, MA

Notable investors

Winklevoss Capital

Frequently asked about Leap Therapeutics funding

How much has Leap Therapeutics raised?

Leap Therapeutics has raised $99M in total disclosed funding across the rounds on record.

Who has invested in Leap Therapeutics?

Winklevoss Capital are named among the investors backing Leap Therapeutics.

What was the latest Leap Therapeutics funding round?

The most recent disclosed round is a Series B.

Where is Leap Therapeutics based?

Leap Therapeutics is based in Cambridge, MA.

Totals shown for Leap Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

Companies related to Leap Therapeutics (26)

• Treasury
• Yellow Card
• n3xt
• Starcity
• Blueprint
• Cypherpunk Technologies (formerly Leap Therapeutics)
• Verdigris Technologies
• Talent Garden
• University of Cambridge
• Cambridge Quantum Computing
• ElevateBio
• Beam Therapeutics
• Earendil Labs
• Suno
• Relay Therapeutics
• Moderna
• Moderna Therapeutics
• CuspAI
• Spyre Therapeutics
• FerGene
• Hemab
• Fog Pharmaceuticals
• Parabilis Medicines
• Valo Health
• Cullinan Oncology
• Superpedestrian

Browse related funding lists (5)

• Series B stage companies
• Startups in Cambridge
• Investors in Cambridge
• Companies that raised 50m 100m
• Companies backed by Winklevoss Capital

Company funding database · Investor directory · Founder database · Mega-rounds 2026